Breaking News

Kemwell Contracted by Mercury

December 7, 2012

Will manufacture tablets at Uppsala

Kemwell AB has signed an agreement with Mercury Pharma Group Ltd. for the manufacture of pharmaceuticals at its new production facility in Uppsala. The agreement covers the manufacture of tablets and release and distribution of products to Great Britain and Ireland.
 
“This agreement shows that we are indeed competitive in Sweden in production. Our new modern facility gives great opportunities for pharmaceutical manufacture in collaboration with both new and existing customers,” said Kemwell’s chief executive officer, Agneta Bergvall.
 
Kemwell is a CMO with production facilities in both India and Sweden. The company was established through the acquisition of a facility from Pfizer, with manufacturing capabilities for tablets, suppositories and capsules.

Related Contract Manufacturing:

Related Packaging:

Related Compliance:

  • Packaging Equipment Technology Preview

    Packaging Equipment Technology Preview

    February 15, 2017
    Today’s complex drug products present challenges; the latest equipment capabilities help overcome them

  • The Good, the Bad, and the Donald

    The Good, the Bad, and the Donald

    January 31, 2017
    Orphan drugs, CMO continuous manufacturing and developing world sales offer biggest revenue opportunities

  • Predictive Analytics and the Future of RBM

    Rajneesh Patil, Senior Director, RBM and Analytics, QuintilesIMS||January 23, 2017
    How advances in Risk-Based Monitoring will enable a more proactive approach to identify and mitigate potential risks